COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,398 Articles (22,816 medRxiv, 8,582 bioRxiv)

Most recent first Previous |  Page 872: Articles 8711-8720  | Next

SARS-CoV-2 harnesses host translational shutoff and autophagy to optimize virus yields: The role of the envelope (E) protein
Waisner, H., Grieshaber, B., Saud, R., Henke, W., Stephens, E. B., Kalamvoki, M.
10.1101/2022.03.24.485734 — Posted: 2022-03-25
Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq
Vazquez, S. E., Mann, S. A., Bodansky, A., Kung, A. F., Quandt, Z., Ferre, E. M. N., Landegren, N., Eriksson, D., Bastard, P., Zhang, S.-Y., Liu, J., Mitchell, A., Mandel-Brehm, C., Miao, B., Sowa, G., Zorn, K., Chan, A. Y., Shimizu, C., Tremoulet, A., Lynch, K., Wilson, M. R., Kämpe, O., Dobbs, K., Delmonte, O. M., Notarangelo, L. D., Burns, J. C., Casanova, J.-L., Lionakis, M. S., Torgerson, T. R., Anderson, M. S., DeRisi, J. L.
10.1101/2022.03.23.485509 — Posted: 2022-03-25
Improved And Optimized Drug Repurposing For The SARS-CoV-2 Pandemic
Issac, D., Cohen, S., Hershcovitch, M., Taraz, M., Kissig, O., Waddington, D., Chin, P., Friedrich, T.
10.1101/2022.03.24.485618 — Posted: 2022-03-24
Neutrophils in severe COVID-19 are characterized by a hyperactive immature state and maintained CXCR2 expression
Rice, C. M., Lewis, P., Ponce-Garcia, F. M., Gibbs, W., Cela, D., Hamilton, F., Arnold, D., Hyams, C., Oliver, E., Barr, R., Goenka, A., Davidson, A., Wooldridge, L., Finn, A., Rivino, L., Amulic, B.
10.1101/2022.03.23.22272828 — Posted: 2022-03-24
Production of anti-spike antibodies in response to COVID vaccine in lymphoma patients
Della Pia, A., Kim, G. Y., Ip, A., Ahn, J., Liu, Y., Koropsak, M., Lukasik, B., Contractor, A., Amin, K., Ayyagari, L., Zhao, C., Gupta, A., Batistick, M., Leslie, L., Goy, A., Feldman, T., Kats, S.
10.1101/2022.03.24.22272883 — Posted: 2022-03-24
The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long Covid or Post-COVID syndrome
Sivan, M., Preston, N. J., Parkin, A., Makower, S., Gee, J., Ross, D., Tarrant, R., Davison, J., Halpin, S., O'Connor, R. J., Horton, M.
10.1101/2022.03.24.22272892 — Posted: 2022-03-24
Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel
Gazit, S., Saciuk, Y., Perez, G., Peretz, A., Pitzer, V. E., Patalon, T.
10.1101/2022.03.24.22272835 — Posted: 2022-03-24
Risk factors for SARS-CoV-2 transmission in student residences: a case-ascertained study in Leuven, Belgium from October 2020 until May 2021
Vanbesien, M., Molenberghs, G., Geenen, C., Thibaut, J., Gorissen, S., Andre, E., raymenants, J.
10.1101/2022.03.23.22272836 — Posted: 2022-03-24
COVID-19 Vaccine Effectiveness against the Omicron BA.2 variant in England
Kirsebom, F., Andrews, N., Stowe, J., Toffa, S., Sachdeva, R., Gallagher, E., Groves, N., O'Connell, A.-M., Chand, M., Ramsay, M., Lopez Bernal, J.
10.1101/2022.03.22.22272691 — Posted: 2022-03-24
Inverse proportionality between height and duration of epidemic peaks not observed for the COVID-19 epidemic in Japan
Tomie, T.
10.1101/2022.03.23.22272840 — Posted: 2022-03-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).